Recent Advances in Cancer Research and Therapy
Editat de Xin-Yuan Liu, Sidney Pestka, Yu-Fang Shien Limba Engleză Hardback – 17 mai 2012
- Includes a wide range of research areas including a focus on biotherapy and the development of novel cancer therapeutic strategies.
- Formatted for a broad audience including all working in researching cancer treatments and therapies.
- Discusses special traits and results of Chinese cancer research.
Preț: 1069.13 lei
Preț vechi: 1125.40 lei
-5% Nou
Puncte Express: 1604
Preț estimativ în valută:
204.63€ • 213.28$ • 170.34£
204.63€ • 213.28$ • 170.34£
Carte tipărită la comandă
Livrare economică 06-20 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780123978332
ISBN-10: 0123978335
Pagini: 700
Dimensiuni: 152 x 229 x 38 mm
Greutate: 1.1 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0123978335
Pagini: 700
Dimensiuni: 152 x 229 x 38 mm
Greutate: 1.1 kg
Editura: ELSEVIER SCIENCE
Public țintă
Scientists, researchers, medical professionals, and students working in the various fields related to cancer research and treatment.Cuprins
1. Biotherapy of Cancer: Progress in China
2. Cancer Targeting Gene-Viro-Therapy (CTGVT) and Its Promising Future
3. Relationship Between Antiproliferative Activities and Class I MHC Surface Expression of Mouse Interferon Proteins on B16-F10 Melanoma Cells
4. Mitotic Regulator Hec1 as a Potential Target for Developing Breast Cancer Therapeutics
5. Advances in Liposome-based Targeted Gene Therapy of Cancer
6. Re-wiring the Intracellular Signaling Network in Cancer
7. Research and Development of Highly Potent Antibody-based Drug Conjugates and Fusion Proteins for Cancer Therapy
8. Cancer Stem Cell
9. p53: A Target and a Biomarker of Cancer Therapy?
10. Recombinant Adenoviral-p53 Agent (Gendicine®): Quality Control, Mechanism of Action, and Its Use for Treatment of Malignant Tumors
11. Three Dimensional Tumor Model and T Lymphocytes Immunotherapy for Cancer
12. Advances in Cancer Chemotherapeutic Drug Research in China
13. Doxorubicin Cardiotoxicity Revisited: ROS versus Top2
14. Biochemistry and Pharmacology of Human ABCC1/MRP1 and Its Role in Detoxification and in Multidrug Resistance of Cancer Chemotherapy
15. The Role of Traditional Chinese Medicine in Clinical Oncology
16. Effect of Arsenic Trioxide on Acute Promyelocytic Lukemia and Glioma: Experimental Studies, Clinical Applications and Perspectives
17. Recent Advance in Nasopharyngeal Carcinoma Research and Its Pathogenesis
18. Esophageal Carcinoma
2. Cancer Targeting Gene-Viro-Therapy (CTGVT) and Its Promising Future
3. Relationship Between Antiproliferative Activities and Class I MHC Surface Expression of Mouse Interferon Proteins on B16-F10 Melanoma Cells
4. Mitotic Regulator Hec1 as a Potential Target for Developing Breast Cancer Therapeutics
5. Advances in Liposome-based Targeted Gene Therapy of Cancer
6. Re-wiring the Intracellular Signaling Network in Cancer
7. Research and Development of Highly Potent Antibody-based Drug Conjugates and Fusion Proteins for Cancer Therapy
8. Cancer Stem Cell
9. p53: A Target and a Biomarker of Cancer Therapy?
10. Recombinant Adenoviral-p53 Agent (Gendicine®): Quality Control, Mechanism of Action, and Its Use for Treatment of Malignant Tumors
11. Three Dimensional Tumor Model and T Lymphocytes Immunotherapy for Cancer
12. Advances in Cancer Chemotherapeutic Drug Research in China
13. Doxorubicin Cardiotoxicity Revisited: ROS versus Top2
14. Biochemistry and Pharmacology of Human ABCC1/MRP1 and Its Role in Detoxification and in Multidrug Resistance of Cancer Chemotherapy
15. The Role of Traditional Chinese Medicine in Clinical Oncology
16. Effect of Arsenic Trioxide on Acute Promyelocytic Lukemia and Glioma: Experimental Studies, Clinical Applications and Perspectives
17. Recent Advance in Nasopharyngeal Carcinoma Research and Its Pathogenesis
18. Esophageal Carcinoma
Recenzii
"While referencing advances in traditional therapies and treatments such as chemotherapy, this book also highlights advances in biotherapy including research using Interferon and Super Interferon, HecI based and liposome based therapy, gene therapy, and p53 based cancer therapy." --Doody.com, April 24, 2013